Gian Parkash Aggarwal sold 15.50 lakh shares, equivalent to a 2.71% stake, at Rs 1,080.04 per share. He held a 10.80% stake in the company as of June 2026.
Innova Captab is a pharmaceutical company with a presence across the pharmaceutical value chain, including research and development, manufacturing, drug distribution, marketing and exports. Through its Contract Development and Manufacturing Organization (CDMO) business, the company offers a range of pharmaceutical products to more than 350 clients in India and key international markets. It also has a direct presence across India and international markets through its Branded Generics business. The company operates five manufacturing facilities comprising nine independent blocks, accredited by global regulatory bodies including WHO-GMP, EU-GMP, UK-MHRA and PIC/S.
On a consolidated basis, Innova Captab's net profit rose 42.26% to Rs 44.13 crore while net sales rose 33.94% to Rs 470.85 crore in Q1 June 2026 over Q1 June 2025.
"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."